Simvastatin treatment to improve patient-reported outcomes in patients with chronic pancreatitis

Active Project Grant Awarded Last action

Award ID
HT94252310150
Recipient
Awarding agency
Obligated
$6,150,467

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 77% complete
Place of performance
West Hollywood, CA 90048, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

This Project Grant award of $6,150,467, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a research project at Cedars-Sinai Medical Center to investigate the use of the drug simvastatin to improve patient-reported outcomes in individuals with chronic pancreatitis. The award has a period of performance from September 30, 2023 to September 29, 2027. As a leading academic medical center, Cedars-Sinai has an extensive track record of conducting high-impact biomedical research for federal agencies, including the Department of Defense, Department of Health and Human Services, and National Science Foundation, through both prime and subcontract awards. This grant project aims to advance the understanding and treatment of chronic pancreatitis, a debilitating condition that affects military service members and veterans.

Subawards

Subrecipient Amount Awarded
University Of Pittsburgh - Of The Commonwealth System Of Higher Education The project is designed to demonstrate the feasibility of a clinical trial to determine the effect of simvastatin on determine on pain, health-related quality… $97,768
Greater LOS Angeles Veterans Research And Education Foundation Perform Subtask 2.1 in Specific Aim 3: Treat rodent acinar cells and pancreatic stellate cells (PSCs) with simvastatin and IL-4R blocking peptide (BP), and… $45,800
The Leland Stanford Junior University The objectives are to develop treatments to improve the outcomes of patients with chronic pancreatitis. Based on preliminary pre-clinical and clinical work,… $96,874
The Leland Stanford Junior University In this grant application, Drs. Sohail Husain, MD and Bomi Lee, PhD will collaborate with the Cedars Sinai group in the ancillary measurements of blood… $148,156
University Of New South Wales The studies to be performed at the UNSW site are designed to address Aim 3 of the grant protocol. Aim 3: To extend the therapeutic benefit of simvastatin, we… $96,599
Greater LOS Angeles Veterans Research And Education Foundation Perform Subtask 2.1 in Specific Aim 3: Treat rodent acinar cells and pancreatic stellate cells (PSCs) with simvastatin and IL-4Rα blocking peptide (BP), and… $45,800

Quick answers

Who received award HT94252310150?

HT94252310150 was awarded to Cedars-Sinai Medical Center by Defense Health Agency (Department of Defense) on September 30, 2023.

How much is award HT94252310150 worth?

$6,150,467 has been obligated on HT94252310150.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login